Browse recent medication, recall, and health-related stories.
Page 21 of 51
BlossomHill Therapeutics, Inc. (BlossomHill Therapeutics), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop... The post Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO appeared first on Legal Desire Media and Insights .
BlossomHill Therapeutics, Inc. (BlossomHill Therapeutics), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop... The post Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO appeared first on Legal Desire Media and Insights .
Dr Muiris Houston: More trials needed before we pass judgment on GLP-1 drugs The Irish Times Strength training is replacing weight loss as the top gym goal — and it has to do with GLP-1s creators.yahoo.com ‘Ozempic Butt’ Isn’t Always Muscle Loss—What Experts Want Patients To Know Newsweek Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits Drug Topics Fact vs. Fiction: Separating the Myths from the Science Behind GLP-1 Medications today.uconn.edu
A Darlington woman diagnosed with breast cancer after losing her mum and both her aunties to the disease is taking on 10,000 steps a day to raise money for charity.
Around one in six people experience infertility, with irregular or absent ovulation among the most common causes. The drug clomiphene citrate has long been a mainstay of fertility treatment, but a growing body of Adelaide University research is raising safety concerns about higher cumulative doses.
Learn how modern Indian diets, stress, irregular meals and low-fibre foods can affect digestion, gut bacteria and overall gut health.
A study of 4,818 middle-aged and older Chinese adults found that higher light BioAge was associated with greater risks of cognitive impairment, episodic memory decline, and reduced mental intactness. The simple measure, based on age, creatinine, glucose, and CRP, added modest predictive information but requires further validation before clinical use.
Heart attack safety tips: What should you do after you spot symptoms of heart attack? Scroll down to know what doctor wants you to know about the first 10minutes after heart attack and what you can do to stay safe!
HONG KONG, Aug. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase II clinical study (AK146D1-202) evaluating AK146D1, the Company's internally developed TROP2/Nectin-4 bispecific antibody-drug conjugate (bsADC),...
(MENAFN - Saving Advice) A Medicare drug plan that looks inexpensive on the surface can become surprisingly costly once you start filling prescriptions. Premiums are only one piece of the equation, ...
Cannabis-related hospitalizations are climbing as more young Americans appear to be embracing it to cope how they perceive the state of the world.
Dr Muiris Houston: More trials needed before we pass judgment on GLP-1 drugs The Irish Times Strength training is replacing weight loss as the top gym goal — and it has to do with GLP-1s creators.yahoo.com ‘Ozempic Butt’ Isn’t Always Muscle Loss—What Experts Want Patients To Know Newsweek Experts Uncertain of GLP-1s’ Long-Term Clinical Benefits Drug Topics Fact vs. Fiction: Separating the Myths from the Science Behind GLP-1 Medications today.uconn.edu
Around one in six people experience infertility, with irregular or absent ovulation among the most common causes. The drug clomiphene citrate has long been a mainstay of fertility treatment, but a growing body of Adelaide University research is raising safety concerns about higher cumulative doses.
A study of 4,818 middle-aged and older Chinese adults found that higher light BioAge was associated with greater risks of cognitive impairment, episodic memory decline, and reduced mental intactness. The simple measure, based on age, creatinine, glucose, and CRP, added modest predictive information but requires further validation before clinical use.
Heart attack safety tips: What should you do after you spot symptoms of heart attack? Scroll down to know what doctor wants you to know about the first 10minutes after heart attack and what you can do to stay safe!
HONG KONG, Aug. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase II clinical study (AK146D1-202) evaluating AK146D1, the Company's internally developed TROP2/Nectin-4 bispecific antibody-drug conjugate (bsADC),...